|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 31/18 | (2006.01) |
| A61K 31/4985 | (2006.01) | ||
| C07D 498/04 | (2006.01) |
| (11) | Number of the document | 3372281 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18166621.5 |
| Date of filing the European patent application | 2006-04-28 | |
| (97) | Date of publication of the European application | 2018-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-07 |
| (46) | Date of publication of the claims translation | 2021-12-10 |
| (30) | Number | Date | Country code |
| 2005131161 | 2005-04-28 | JP | |
| 2005312076 | 2005-10-27 | JP |
| (72) |
Johns, Brian Alvin , US
Kawasuji, Takashi , JP
Taishi, Teruhiko , JP
Taoda, Yoshiyuki , JP
|
| (73) |
VIIV Healthcare Company ,
251 Little Falls Drive, Wilmington, DE 19808,
US
Shionogi & Co., Ltd , 1-8, Doshomachi 3 chome Chuo-Ku, Osaka 541-0045, JP |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Policiklinis karbamoilpiridono darinys, turintis ŽIV integrazės inhibitorinį aktyvumą |
| POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2025-03-19 | 20 | 347.00 EUR |